N180735 N1 Ruling Active

The tariff classification of the Japanese Encephalitis virus vaccine from China

Issued September 7, 2011 by U.S. Customs and Border Protection.

Tariff classification

HTS codes: 3002.20.0000

Headings: 3002

Product description

The subject merchandise is a single frozen aliquot of the Japanese Encephalitis Vaccine SA 14-14-2 vaccine virus which contains live attenuated Japanese encephalitis virus, buffer salts, sugars and human serum albumin with a dilute of sterile water for injection presented in a vial. The material is indicated for research & development and will be used solely for in-vitro analysis.

CBP rationale

The applicable subheading for Japanese Encephalitis Vaccine the will be 3002.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine”.

Full text

N180735 September 7, 2011 CLA-2-30:OT:RR:E:NC:N2:N238 CATEGORY: Classification TARIFF NO.: 3002.20.0000 Ms. Paula Swanson Sanofi Pasteur, Inc. Discovery Drive Swiftwater, PA 18370 RE: The tariff classification of the Japanese Encephalitis virus vaccine from China Dear Ms. Swanson: In your letter dated August 16, 2011, you requested a tariff classification ruling. The subject merchandise is a single frozen aliquot of the Japanese Encephalitis Vaccine SA 14-14-2 vaccine virus which contains live attenuated Japanese encephalitis virus, buffer salts, sugars and human serum albumin with a dilute of sterile water for injection presented in a vial. The material is indicated for research & development and will be used solely for in-vitro analysis. The applicable subheading for Japanese Encephalitis Vaccine the will be 3002.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine”. The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact the National Import Specialist at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

Searching CBP rulings the smart way

TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.

Book a demo →